SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-18-002946
Filing Date
2018-07-02
Accepted
2018-07-02 13:16:55
Documents
2
Period of Report
2018-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_070218.htm 8-K 42057
2 PRESS RELEASE DISTRIBUTION AGREEMENT ex99-1.htm EX-99.1 10735
  Complete submission text file 0001387131-18-002946.txt   54069
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 18931978
SIC: 2834 Pharmaceutical Preparations